AnaptysBio Inc (ANAB):企業の財務・戦略的SWOT分析

◆英語タイトル:AnaptysBio Inc (ANAB) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH134569FSA
◆発行会社(調査会社):GlobalData
◆発行日:2020年12月
◆ページ数:52
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

AnaptysBio Inc (ANAB) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

AnaptysBio Inc (AnaptysBio) is a clinical-stage biotechnology company that focuses on the development of antibody product candidates for the treatment of inflammatory, autoimmune and atopic diseases. The company develops its product candidates through its proprietary antibody discovery technology platform, that is based on somatic hypermutation (SHM). Its product candidates are being developed for the treatment of moderate-to-severe adult atopic dermatitis, asthma, generalized pustular psoriasis and palmo-plantar pustular psoriasis and for the treatment of human autoimmune diseases. The company has partnership with GlaxoSmithKline and Bristol-Myers Squibb, to develop its product candidates. AnaptysBio is headquartered in San Diego, California, the US.

AnaptysBio Inc Key Recent Developments

Nov 04,2020: AnaptysBio announces third quarter 2020 financial results and provides pipeline updates
Aug 10,2020: AnaptysBio announces second quarter 2020 financial results and provides pipeline updates
Jul 31,2020: Anaptysbio appoints Dr. Paul F. Lizzul as chief medical officer
Jul 15,2020: AnaptysBio expands executive leadership team
May 06,2020: AnaptysBio announces first quarter 2020 financial results and provides pipeline updates

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
AnaptysBio Inc – Key Facts
AnaptysBio Inc – Key Employees
AnaptysBio Inc – Key Employee Biographies
AnaptysBio Inc – Major Products and Services
AnaptysBio Inc – History
AnaptysBio Inc – Company Statement
AnaptysBio Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
AnaptysBio Inc – Business Description
AnaptysBio Inc – Corporate Strategy
AnaptysBio Inc – SWOT Analysis
SWOT Analysis – Overview
AnaptysBio Inc – Strengths
AnaptysBio Inc – Weaknesses
AnaptysBio Inc – Opportunities
AnaptysBio Inc – Threats
AnaptysBio Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
AnaptysBio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
AnaptysBio Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
AnaptysBio Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Nov 04, 2020: AnaptysBio announces third quarter 2020 financial results and provides pipeline updates
Aug 10, 2020: AnaptysBio announces second quarter 2020 financial results and provides pipeline updates
Jul 31, 2020: Anaptysbio appoints Dr. Paul F. Lizzul as chief medical officer
Jul 15, 2020: AnaptysBio expands executive leadership team
May 06, 2020: AnaptysBio announces first quarter 2020 financial results and provides pipeline updates
Mar 02, 2020: AnaptysBio announces fourth quarter and full year 2019 financial results and provides pipeline updates
Nov 08, 2019: AnaptysBio announces third quarter 2019 financial results and provides pipeline updates
Aug 08, 2019: AnaptysBio announces second quarter 2019 financial results and provides pipeline updates
May 07, 2019: AnaptysBio announces first quarter 2019 financial results and provides pipeline updates
Feb 28, 2019: AnaptysBio announces fourth quarter and full year 2018 financial results and provides pipeline updates
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
AnaptysBio Inc, Key Facts
AnaptysBio Inc, Key Employees
AnaptysBio Inc, Key Employee Biographies
AnaptysBio Inc, Major Products and Services
AnaptysBio Inc, History
AnaptysBio Inc, Subsidiaries
AnaptysBio Inc, Key Competitors
AnaptysBio Inc, Ratios based on current share price
AnaptysBio Inc, Annual Ratios
AnaptysBio Inc, Annual Ratios (Cont...1)
AnaptysBio Inc, Interim Ratios
AnaptysBio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
AnaptysBio Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
AnaptysBio Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[AnaptysBio Inc (ANAB):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • UNIQA Serbia:企業の戦略・SWOT・財務情報
    UNIQA Serbia - Strategy, SWOT and Corporate Finance Report Summary UNIQA Serbia - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Guangshen Railway Company Limited:戦略・SWOT・企業財務分析
    Guangshen Railway Company Limited - Strategy, SWOT and Corporate Finance Report Summary Guangshen Railway Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • NeuroVive Pharmaceutical AB (NVP):企業の財務・戦略的SWOT分析
    Summary NeuroVive Pharmaceutical AB (NeuroVive), formerly NeuroPharma i Sverige AB focuses on the research and development of mitochondrial therapies. The company’s programs include NeuroSTAT, a clinical phase II drug candidate for the prevention of traumatic brain injury; and phase I KL1333, a nove …
  • Bowler Metcalf Limited:企業の戦略・SWOT・財務情報
    Bowler Metcalf Limited - Strategy, SWOT and Corporate Finance Report Summary Bowler Metcalf Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Monteloeder S.L.:企業の戦略・SWOT・財務情報
    Monteloeder S.L. - Strategy, SWOT and Corporate Finance Report Summary Monteloeder S.L. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Unum Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Unum Therapeutics Inc (Unum) is a cancer cell therapy company that discovers, develops, and commercializes novel antibody-coupled cellular immunotherapies. The company uses its proprietary Antibody-Coupled T-cell Receptor (ACTR) technology for discovering and developing new cellular immunoth …
  • Sembcorp Industries Ltd (U96)-石油・ガス分野:企業M&A・提携分析
    Summary Sembcorp Industries Limited (Sembcorp) is a diversified energy, water and marine company. The company’s utilities division provides energy and water to industrial and municipal customers. Its energy operations include power generation, steam production and supply and natural gas import suppl …
  • Civica Group Limited:企業の戦略的SWOT分析
    Civica Group Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Celixir Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Celixir Ltd (CTL), formerly Cell Therapy Ltd is a biotechnology company that discovers and develops regenerative medicines using adult stem cells for the treatment of heart failure. The company provids heartcel which is a type of stem cell therapy that provides improved outcomes for end-stag …
  • Fujifilm Holdings Corp (FUJIY):企業の財務・戦略的SWOT分析
    Fujifilm Holdings Corp (FUJIY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • CK Infrastructure Holdings Ltd (1038):電力:M&Aディール及び事業提携情報
    Summary CK Infrastructure Holdings Limited (CKI), a subsidiary of CK Hutchison Holdings Limited, is an infrastructure investment company. It holds diversified investment interests across various sectors including energy, rail transportation, water, waste management, and other infrastructure related …
  • SunPower Corporation (SPWR):電力:M&Aディール及び事業提携情報
    Summary SunPower Corporation (SunPower), a subsidiary of Total Solar International SAS, is a provider of solar technology and energy services. The company has a presence in solar value chain from cell and panel manufacturing, project development, project finance through engineering, procurement, and …
  • Berry Global Group, Inc.:企業の戦略・SWOT・財務情報
    Berry Global Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Berry Global Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • DBK Pharmaceutical:製薬・医療:M&Aディール及び事業提携情報
    Summary DBK Pharmaceutical (DBK Pharma) is a pharmaceutical company that develops, manufactures and markets pharmaceutical, herbal brands, food supplements, cosmetics and veterinary products. The company’s pharmaceutical products include chitocal capsule, debeskon, rentensar tablets, pressothioval, …
  • Ameren Corporation:企業の戦略・SWOT・財務情報
    Ameren Corporation - Strategy, SWOT and Corporate Finance Report Summary Ameren Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Amneal Pharmaceuticals Inc:企業のM&A・事業提携・投資動向
    Amneal Pharmaceuticals Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Amneal Pharmaceuticals Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Novadaq Technologies Inc. (NDQ)-医療機器分野:企業M&A・提携分析
    Summary Novadaq Technologies Inc. (Novadaq) is a medical imaging company. It develops, manufactures and markets real-time fluorescence imaging technology products. The company’s SPY Imaging Technology products include SPY Elite open surgical imaging system, PinPoint endoscopic fluorescence imaging s …
  • Vostok New Ventures Ltd (VNV SDB):企業の財務・戦略的SWOT分析
    Summary Vostok New Ventures Ltd (Vostok New Ventures), formerly Vostok Nafta Investment Ltd, is an investment company that identifies and invests in assets. The company carries out partial and complete liquidation of holding and group’s holding companies. It identifies and invests in unlisted compan …
  • Starpharma Holdings Ltd (SPL):医療機器:M&Aディール及び事業提携情報
    Summary Starpharma Holdings Ltd (Starpharma) is a biotechnology company, which researches, develops and manufactures dendrimer products for pharmaceutical, life sciences and other applications. Dendrimers are synthetic nanoscale polymers with pharmaceutical and medical uses. The company’s developmen …
  • HoMedics LLC:企業の戦略的SWOT分析
    HoMedics LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆